PROTECTIVE EFFECT OF NEBIVOLOL ON ALUMINIUM-INDUCED NEUROBEHAVIORAL AND BIOCHEMICAL ALTERATIONS IN RATS
Keywords:Nebivolol, Aluminium chloride, Neurotoxicity, Modified elevated plus maze
Objective: The present study was designed to investigate the neuroprotective potential of nebivolol, a Î²1 adrenergic blocker on aluminium-induced neurobehavioral and biochemical alterations in rats.
Methods: The neurotoxicity was induced by administration of aluminium (50 mg/kg/day, p.o.) for 5 weeks. Nebivolol was administered at a dose of 10 mg/kg, p.o. for 5 weeks. Behavioral assessments were done by using open field test and modified elevated plus maze (mEPM) test. At the end of the study, oxidative stress parameters were determined and histopathological studies of cerebral cortex of rat brains were performed.
Results: Aluminium chloride treated rats showed significant reduction in motor activity in open field test and memory impairment in mEPM test as compared to control group. Nebivolol significantly reversed these parameters and restored brain antioxidant defensive enzymes with reduction in lipid peroxidation. The neurotoxicity was confirmed by the histopathological analysis of cerebral cortex of rat brains. Aluminium treated animals showed presence of ghost cells, vacuolated cytoplasm and haemorrhage in rat cerebral cortex, indicating neurotoxicity. Nebivolol attenuated all these changes. Thus, the potential of nebivolol to prevent aluminium-induced neurotoxicity was also reflected at microscopic level, indicative of its neuroprotective effects.
Conclusion: Nebivolol showed significant antioxidant and neuroprotective activities against aluminium-induced neuronal degeneration. The results of the present study strengthen oxidative stress hypothesis of aluminium-induced neurotoxicity and suggest beneficial role of nebivolol in the treatment of neurodegenerative disorders.
Solfrizzi V, Colacicco AM, Dâ€™Introno A, Capurso C, Parigi AD, Capurso SA et al. Macronutrients, aluminium from drinking water and foods, and other metals in cognitive decline and dementia. J Alzheimerâ€™s Dis 2006;10:303-30.
Bharathi VP, Govindaraju M, Palanisamy AP, Sambartimu K, Rao KSJ. Molecular toxicity of aluminium in relation to neurodegeneration. Indian J Med Res 2008;128:545-56.
Kaneko N, Sugioka T, Sakurai H. Aluminium compounds enhance lipid peroxidation in liposomes:insight into cellular damage caused by oxidative stress. J Inorganic Biochem. 2007;101:967-75.
Kaur A, Gill KD. Disruption of neuronal calcium homeostasis after chronic aluminium toxicity in rats. Basic Clin Pharmacol Toxicol. 2005;96:118-22.
Amador FC, Santos MS, Oliveira CR. Lipid peroxidation and aluminium effects on the cholinergic system in nerve terminals. Neurotox Res. 2001;3:223-33.
Ravi SM, Prabhu BM, Raju TR, Bindu PN. Long term effects of post natal aluminium exposure on acetylcholinesterase activity and biogenic amine neurotransmitters in rat brain. Indian J Physiol Pharmacol. 2000;4:443-78.
Cordeiro JM, Silva VS, Oliveira CR, Goncalves PP. Aluminium-induced impairment of Ca2+ modulatory action on GABA transport in brain cortex nerve terminals. J Inorg Biochem. 2003;97:132-42.
Grisaru D, Sternfeld M, Eldor A, Glick D, Soreq H. Structural roles of acetylcholinesterase variants in biology and pathology. Eur J Biochem. 1999;264:672-86.
Nayak P, Chatterjee AK. Effects of aluminium exposure on brain glutamate and GABA systems:an experimental study in rats. Food Chem Toxicol. 2001;39:1285-9.
Vlahogianni T, Dassenakis M, Scoullos MJ, Valavanidis, A. Integrated use of biomarkers (superoxide dismutase, catalase and lipid peroxidation) in muscles Mytilus galloprovincialis for assessing heavy metalsâ€™ pollution in coastal areas from the Saronikos Gulf of Greece. Mar Pollut Bull. 2007;54:1361-71.
De Groot AA, Mathy MJ, Van Zwieten PA, Peters SL. Antioxidant activity of nebivolol in the rat aorta. J Cardiovasc Pharmacol. 2004;43:148-53.
Oelze M, Daiber A, Brandes RP, Hortmann M, Wenzel P, Hink U. Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension. 2006;48:677-84.
Heeba GH, El-Hanafy AA. Nebivolol regulates eNOS and iNOS expressions and alleviates oxidative stress in cerebral ischemia/reperfusion injury in rats. Life Sci. 2012;90:388-95.
Nade VS, Shendye NV, Kawale LA, Patil NR, Khatri ML. Protective effect of nebivolol on reserpine-induced neurobehavioral and biochemical alterations in rats. Neurochem Int. 2013;63:316-21.
Jyoti A, Sharma D, Sethi P. Bacopa monniera prevents from aluminium neurotoxicity in the cerebral cortex of rat brain. J Ethnopharmacol. 2007;111:56-62.
JÃ¤rbe TUC, Ross T, DiPatrizio NV, Pandarinathan L, Makriyannis A. Effects of the CB1R agonist WIN-55,212-2 and the CB1R antagonists SR-141716 and AM-1387:Open-field examination in rats. Pharmacol Biochem Behav. 2006;85:243-52.
Itoh J, Nabeshima T, Kameyama T. Utility of an elevated plus-maze for the evaluation of memory in mice:effects of nootropics scopolamine and electroconvulsive shock. Psychopharmacol. 1990;101:27-33.
Hlinak Z, Krejci I. Oxiracetam prevents the MK-801 induced amnesia for the elevated plus-maze in mice. Behav Brain Res. 2000;117:147-51.
Naidu PS, Singh A, Kulkarni SK. Effect of Withania somnifera roots extract on haloperidol induced orofacial dyskinesia:possible mechanism of action. J Med Food. 2003;6:107-14.
Luck H. Catalase. In:Bergmeyer H, editor. Methods of enzymatic analysis. New York:Academic Press;1971. 885â€“93.
Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82:70-7.
Kono Y. Generation of superoxide radical during autooxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys. 1978;186:189-95.
Wills ED. Mechanism of lipid peroxide formation in animal tissues. Biochem J. 1996;99:667-76.
Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folinâ€“ Phenol reagent. J Biol Chem. 1951;193:265-75.
Bowdler NC, Beasley DS, Fritze EC, Goulette AM, Hatton JD, Hession J et al. Behavioural effects of aluminium ingestion on animal and human subjects. Pharmacol Biochem Behav. 1979;10:505-12.
Kaneko N, Sugioka T, Sakurai H. Aluminium compounds enhance lipid peroxidation in liposomes:insight into cellular damage caused by oxidative stress. J Inorg Biochemistry. 2007;101:967-75.
Fukui K, Onodera K, Shinkai T, Suzuki S, Urano S. Impairment of learning and memory in rats caused by oxidative stress and aging, and changes in antioxidative defense systems. Ann N Y Acad Sci. 2000;928:168-75.
Deloncle R, Guillard O. Mechanism of Alzheimerâ€™s disease:arguments for a neurotransmitter aluminium complex implication. Neurochem Res. 1990;15:1239-45.
Lakshmana MK, Rao BS, Dhingra NK, Ravikumar R, Govindaiah R, Meti BL et al. Chronic (âˆ’) deprenyl administration increases dendritic arborization in CA3 neurons of hippocampus and AChE activity in specific regions of primate brain. Brain Res. 1998;796:38-44.